Late Toxicity of Radiation for Breast Cancer: Overblown or Underappreciated?

Late Toxicity of Radiation for Breast Cancer: Overblown or Underappreciated? is organized by American Society for Radiation Oncology (ASTRO).

Start Date:Dec 13, 2017
Expire Date:Dec 12, 2020

Accreditation:
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Course Description:
This session will focus on late toxicity of radiation for breast cancer, with the theme of whether these risks are overblown or under-appreciated. Along with the introduction and a question and answer session, there are four videos, each approximately 15 minutes:

• Impact of Radiation on Reconstruction after Mastectomy
• Risk of Lymphedema after Radiation for Breast Cancer
• Risk of Cardiac Morbidity and Mortality after Radiation for Breast Cancer
• Risk of Second Malignancy after Radiation for Breast Cancer
• The focus will be on tailored risk assessment for each of these potential toxicities, considerations for including risk of toxicity in management decisions, and toxicity management strategies.

Learning Objectives:
After this session, attendees should be able to:
• Define the impact of radiation on reconstruction after mastectomy.
• Identify lymphedema risks and apply strategies for risk reduction.
• Identify cardiac risks and develop tools for including risk assessment in management decisions.